Hasegawa G R
Drug Intell Clin Pharm. 1984 Apr;18(4):313-4. doi: 10.1177/106002808401800409.
A case of skin necrosis caused by subcutaneously administered heparin is reported. A 76-year-old woman received subcutaneous injections of porcine sodium heparin twice a day to prevent deep vein thrombosis. Nineteen days after heparin therapy began, black necrotic areas were noted on her abdomen, and heparin injections were discontinued. The patient received small amounts of heparin intravenously for three additionally days without apparent complications. Proposed mechanisms for heparin-induced skin necrosis include allergic vasculitis and localized platelet aggregation with intravascular thrombosis. Heparin therapy should be stopped if necrosis develops. Intravenous administration of heparin to sensitive patients may be followed by life-threatening reactions. Necrotic areas may heal spontaneously, but often require debridement and skin grafting. Various agents, including steroids, may be useful in preventing the development of necrotic lesions.
报告了1例皮下注射肝素引起皮肤坏死的病例。一名76岁女性每天接受两次猪源肝素皮下注射以预防深静脉血栓形成。肝素治疗开始19天后,其腹部出现黑色坏死区域,遂停用肝素注射。患者额外接受了3天小剂量静脉注射肝素,未出现明显并发症。肝素诱导皮肤坏死的可能机制包括过敏性血管炎和局部血小板聚集伴血管内血栓形成。如果发生坏死,应停止肝素治疗。对敏感患者静脉注射肝素可能会引发危及生命的反应。坏死区域可能会自行愈合,但通常需要清创和皮肤移植。包括类固醇在内的各种药物可能有助于预防坏死性病变的发生。